🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Pennsylvania › Philadelphia

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Philadelphia, PA

26 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Ap rekriteFaz 3
  • Thomas Jefferson University Hospital, Philadelphia
  • Jefferson Torresdale Hospital, Philadelphia
  • Asplundh Cancer Pavilion, Willow Grove · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06992427

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #98, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Ap rekriteFaz 3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07276399

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Thomas Jefferson University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Ap rekriteFaz 3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04892173

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 1
  • University of Pennsylvania, Philadelphia
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT07219212

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Thomas Jefferson University Hospital, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
  • Jefferson Torresdale Hospital, Philadelphia
Laj 18 a 79 · Tout sèks · Mizajou Sep 22, 2026 · NCT04671667

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2
  • Fox Chase Cancer Center, Philadelphia
  • Temple University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 2
  • Research Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06535607

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06163534

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07216105

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Asplundh Cancer Pavilion, Willow Grove · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06769698

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Philadelphia
  • Normunity Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • Thomas Jefferson University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Ap rekriteFaz 3
  • Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi lwen
  • Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT03526835

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Ap rekriteFaz 1
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 12, 2026 · NCT06747390

Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

Ap rekriteFaz 1
  • Fox Chase Cancer Center, Philadelphia
  • Temple University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT07455032

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06064877

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07030257

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Ap rekrite
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT05031910

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Ap rekriteFaz 1
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06778863

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Ap rekriteFaz 3
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 15, 2025 · NCT06699212

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.